PaySign, Inc. (NASDAQ:PAYS) Receives $12.33 Consensus Price Target from Analysts

Share on StockTwits

PaySign, Inc. (NASDAQ:PAYS) has received an average rating of “Buy” from the six brokerages that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $12.33.

Several equities analysts have recently commented on PAYS shares. ValuEngine lowered PaySign from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research upgraded PaySign from a “hold” rating to a “buy” rating and set a $15.00 price target on the stock in a research note on Saturday. BTIG Research reiterated a “hold” rating on shares of PaySign in a research note on Monday. Maxim Group reiterated a “buy” rating and issued a $10.00 target price on shares of PaySign in a research note on Wednesday, May 8th. Finally, LADENBURG THALM/SH SH assumed coverage on PaySign in a research note on Thursday, May 16th. They issued a “buy” rating and a $12.00 target price on the stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Resources Investment Advisors LLC. purchased a new position in PaySign in the second quarter valued at about $6,290,000. Renaissance Technologies LLC purchased a new position in PaySign in the second quarter valued at about $5,026,000. Russell Investments Group Ltd. purchased a new position in PaySign in the second quarter valued at about $3,267,000. Calamos Advisors LLC purchased a new position in PaySign in the second quarter valued at about $3,069,000. Finally, Acadian Asset Management LLC purchased a new position in PaySign in the second quarter valued at about $2,621,000. Institutional investors own 11.88% of the company’s stock.

Shares of PaySign stock opened at $13.30 on Friday. The stock has a market capitalization of $630.31 million, a price-to-earnings ratio of 147.78 and a beta of 0.73. PaySign has a 12 month low of $2.63 and a 12 month high of $18.67. The company’s fifty day moving average price is $14.22.

PaySign (NASDAQ:PAYS) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.03 EPS for the quarter, beating the consensus estimate of $0.02 by $0.01. The firm had revenue of $8.64 million for the quarter, compared to analyst estimates of $8.48 million. PaySign had a return on equity of 66.14% and a net margin of 13.90%. The business’s revenue for the quarter was up 58.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.03 earnings per share. Equities analysts forecast that PaySign will post 0.29 earnings per share for the current year.

PaySign Company Profile

PaySign, Inc provides prepaid card programs and processing services under the PaySign brand to corporations, government agencies, universities, and other organizations. The company offers various services, including transaction processing, cardholder enrollment, value loading, cardholder account management, reporting, and customer service through PaySign, a proprietary card-processing platform.

Read More: What is the Rule of 72?

Receive News & Ratings for PaySign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PaySign and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Downgrades BP Midstream Partners  to Neutral
JPMorgan Chase & Co. Downgrades BP Midstream Partners to Neutral
Banco Santander Brasil  Rating Lowered to Sell at ValuEngine
Banco Santander Brasil Rating Lowered to Sell at ValuEngine
Blackstone Mortgage Trust  Lifted to Hold at Zacks Investment Research
Blackstone Mortgage Trust Lifted to Hold at Zacks Investment Research
Caci International  Stock Rating Upgraded by Credit Suisse Group
Caci International Stock Rating Upgraded by Credit Suisse Group
Guggenheim Upgrades Cardinal Health  to Buy
Guggenheim Upgrades Cardinal Health to Buy
CBL & Associates Properties  Downgraded by Zacks Investment Research
CBL & Associates Properties Downgraded by Zacks Investment Research


© 2006-2019 Ticker Report